Menopause Blind Spot Costs U.S. Employers $1.8 Billion in Missed Workdays

Menopause-related missed workdays cost U.S. employers an estimated $1.8 billion annually.

Around 1 billion women globally, including nearly 50 million in the U.S. workforce aged 35 and over, are affected by perimenopause, menopause, or postmenopause. This demographic shift has elevated menopause as a critical business concern, given its influence on workforce performance and retention. Yet, workplace support remains uneven or lacking.

Menopause symptoms such as brain fog, disrupted sleep, and fatigue undermine employee focus, motivation, and decision-making. The Mayo Clinic estimates $1.8 billion annually in missed workdays and notes related healthcare costs exceed $24 billion each year in the U.S. Unsupported symptoms contribute to burnout, disengagement, turnover, and early retirement, further straining employers managing talent pipelines. Despite investments in leadership and well-being, menopause itself often escapes organizational strategies.

While no specific timeline for change is noted, the recognition of menopause as a workforce strategy issue signals a potential shift in employer priorities.

For Montana businesses, where workforce retention and productivity are vital amid geographic and demographic challenges, menopause-related support could become an important factor. Employers there might find addressing this issue beneficial for sustaining key talent, especially as women increasingly occupy influential roles during this life stage.

Why menopause is employers’ $1.8 billion blind spot—and what leaders can do about it
By Linia Patel, Fast Company